Literature DB >> 9259939

Antenatally detectable markers for the diagnosis of autosomally trisomic fetuses in at-risk pregnancies.

H M Salihu1, R Boos, W Schmidt.   

Abstract

Our aim was to investigate the contribution of certain antenatally detectable markers leading to the diagnosis of trisomic fetuses we observed over a period of 6 years. In our study, we specifically analyzed the role played by advanced maternal age and sonographically discovered abnormalities in the detection of autosomal trisomies. All together, 27 fetuses had this disorder, representing 28.7% (27 of 94) of all cytogenetic aberrations detected at our center over the same period. Down syndrome (12 cases) and Edward syndrome (11 cases) were the most common trisomies, while 4 cases of Patau syndrome were also diagnosed. The most common indication leading to diagnosis was abnormal ultrasound finding (48.2%), followed by advanced maternal age (44.4%). However, 63% of the trisomic fetuses belonged to mothers aged 35 years and above. Down syndrome fetuses (41.7%) had prenatally detected sonographic anomalies, 63.6% for Edward syndrome, and all fetuses with Patau syndrome (4 of 4) showed abnormal sonographic signs. Trisomy 21 presented with the following features: hydramnios, complex malformations, pyelectasis, and duodenal atresia. Trisomy 18 fetuses showed hydramnios, intrauterine growth retardation, microcephaly, spina bifida, and nonimmune hydrops fetalis. Signs observed in fetuses with trisomy 13 were: hydrocephalus, intrauterine growth retardation, oligoanhydramnios, complex malformations, severe fetal bradycardia and hydronephrosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259939     DOI: 10.1055/s-2007-994139

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  3 in total

1.  Cerebellar cortical-layer-specific control of neuronal migration by pituitary adenylate cyclase-activating polypeptide.

Authors:  D B Cameron; L Galas; Y Jiang; E Raoult; D Vaudry; H Komuro
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

Review 2.  Role of PACAP in controlling granule cell migration.

Authors:  Donald Bryant Cameron; Emilie Raoult; Ludovic Galas; Yulan Jiang; Kimberly Lee; Taofang Hu; David Vaudry; Hitoshi Komuro
Journal:  Cerebellum       Date:  2009-06-23       Impact factor: 3.847

3.  Expression of the human PAC1 receptor leads to dose-dependent hydrocephalus-related abnormalities in mice.

Authors:  Bing Lang; Bing Song; Wendy Davidson; Alastair MacKenzie; Norman Smith; Colin D McCaig; Anthony J Harmar; Sanbing Shen
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.